Home World News Page 42

World News

Latest

Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among...

Ogkologos - August 25, 2025

FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma

Ogkologos - August 22, 2025

Clinical Benefit and Genomic Features Associations Observed with Pembrolizumab Plus Axitinib...

Ogkologos - August 21, 2025

Adagrasib Improves PFS Over Docetaxel in Patients with Previously Treated KRASG12C-mutated...

Ogkologos - August 20, 2025

No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in...

Ogkologos - August 19, 2025

EMA Recommends Granting a Marketing Authorisation for Belantamab Mafodotin

Ogkologos - August 18, 2025

ESMO Joins the European Health Alliance on Alcohol (EHAA) Seeking to...

Ogkologos - August 14, 2025

CLDN18.2-Specific CAR T-Cell Therapy Prolongs PFS in Patients with Previously Treated...

Ogkologos - August 14, 2025

FDA Approves Tafasitamab-cxix for Relapsed or Refractory Follicular Lymphoma

Ogkologos - August 14, 2025

EMA Recommends Granting a Marketing Authorisation for Vorasidenib

Ogkologos - August 13, 2025

1...414243...432 Page 42 of 432

MOST POPULAR

EMA Recommends Refusal of the Marketing Authorisation for Pexidartinib

July 3, 2020

Significantly Longer PFS with First-line Pembrolizumab for MSI-H/dMMR mCRC

December 3, 2020

Adjuvant Everolimus Does Not Improve Recurrence-Free Survival Among Patients with Renal...

August 9, 2023

Targeting the Accomplice: A Potential Treatment Approach for Rhabdomyosarcoma

August 3, 2022

HOT NEWS

FDA Approves Belzutifan for Advanced Renal Cell Carcinoma

Are differences in treatment driving variation in ovarian cancer survival internationally?

Addressing Common Concerns Around Taking Opioids for Cancer-Related Pain: An Expert...

With 3 Years Minimum Follow-Up, Nivolumab Plus Ipilimumab Continues to Provide...